Tag: oncology

Healthcare

Cancer Targeted Therapies and Immunotherapies | Resisting Competitive Pressures

[tweetmeme source= "informa_oz" only_single=false] Drug developers aiming to emulate the success of cancer targeted therapies and immunotherapy brands will struggle as a result of heightened competition and pharmacoeconomic constraints, suggests independent market analyst, Datamonitor. Over the last decade the targeted therapies and immunotherapies class has fuelled growth in the oncology market, making it very attractive…

28 Sep 2010, by Informa Insights